Clinical trials offer early access to cutting-edge treatments that can lead to progress in research, improved treatment options, and better outcomes. Through clinical trials, researchers can better understand how to diagnose, treat, and prevent diseases or conditions, which brings us one step closer to a world without autoimmune disease.
A Study of Mavorixafor in Participants with Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/ or Serious Infections
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Multi-site, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of O3FA supplementation on improving myositis disease activity, including muscle strength and function and other elements of disease activity, and quality of life in patients with mild to moderately active Dermatomyositis (DM)/Juvenile Dermatomyositis (JDM).
This patient usability study is for adults in the United States with Psoriatic Arthritis or Rheumatoid Arthritis who currently use, or have used within the last 6 months, the Orencia® (abatacept) autoinjector. The study will help researchers understand real patient needs and device experience as future autoinjector device options are explored.
The PROPEL Study will test an investigational treatment for generalized myasthenia gravis (gMG) called IMVT-1402 to see if it may help the body’s muscles get the signals they need to work properly.
Browse current studies with filters that allow you to search by condition, treatment, location, and more.
